Követés
Raymond Lai
Raymond Lai
E-mail megerősítve itt: ualberta.ca
Cím
Hivatkozott rá
Hivatkozott rá
Év
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris, CM Chu, VCC Cheng, KS Chan, IFN Hung, LLM Poon, KI Law, ...
The lancet 361 (9371), 1767-1772, 2003
31172003
Human infection with influenza H9N2
M Peiris, KY Yuen, CW Leung, KH Chan, PLS Ip, RWM Lai, WK Orr, ...
The Lancet 354 (9182), 916-917, 1999
14451999
Viral loads and duration of viral shedding in adult patients hospitalized with influenza
N Lee, PKS Chan, DSC Hui, TH Rainer, E Wong, KW Choi, GCY Lui, ...
The Journal of infectious diseases 200 (4), 492-500, 2009
6432009
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
S Shishodia, HM Amin, R Lai, BB Aggarwal
Biochemical pharmacology 70 (5), 700-713, 2005
6252005
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma
J Spratlin, R Sangha, D Glubrecht, L Dabbagh, JD Young, C Dumontet, ...
Clinical Cancer Research 10 (20), 6956-6961, 2004
5192004
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer
JJ Farrell, H Elsaleh, M Garcia, R Lai, A Ammar, WF Regine, R Abrams, ...
Gastroenterology 136 (1), 187-195, 2009
5172009
Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel
P Seve, J Mackey, S Isaac, O Tredan, PJ Souquet, M Perol, R Lai, ...
Molecular Cancer Therapeutics 4 (12), 2001-2007, 2005
3522005
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic …
R Marechal, JR Mackey, R Lai, P Demetter, M Peeters, M Polus, CE Cass, ...
Clinical cancer research 15 (8), 2913-2919, 2009
3242009
Pathobiology of ALK+ anaplastic large-cell lymphoma
HM Amin, R Lai
Blood, The Journal of the American Society of Hematology 110 (7), 2259-2267, 2007
3092007
Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells
Q Lin, R Lai, LR Chirieac, C Li, VA Thomazy, I Grammatikakis, ...
The American journal of pathology 167 (4), 969-980, 2005
2892005
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice
Y Ma, W Cui, J Yang, J Qu, C Di, HM Amin, R Lai, J Ritz, DS Krause, ...
Blood 108 (8), 2726-2735, 2006
2872006
Cryptococcosis in apparently immunocompetent patients
G Lui, N Lee, M Ip, KW Choi, YK Tso, E Lam, S Chau, R Lai, CS Cockram
Journal of the Association of Physicians 99 (3), 143-151, 2006
2722006
Outcomes of adults hospitalised with severe influenza
N Lee, KW Choi, PKS Chan, DSC Hui, GCY Lui, BCK Wong, RYK Wong, ...
Thorax 65 (6), 510-515, 2010
2662010
Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma
EJ Schlette, LJ Medeiros, A Goy, R Lai, GZ Rassidakis
Journal of clinical oncology 22 (9), 1682-1688, 2004
2642004
Micelles of poly(ethylene oxide)‐b‐poly(ε‐caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin
Z Ma, A Haddadi, O Molavi, A Lavasanifar, R Lai, J Samuel
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2008
2532008
Fecal viral load and norovirus-associated gastroenteritis
MCW Chan, JJY Sung, RKY Lam, PKS Chan, NLS Lee, RWM Lai, ...
Emerging infectious diseases 12 (8), 1278, 2006
2412006
Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma
HM Amin, TJ McDonnell, Y Ma, Q Lin, Y Fujio, K Kunisada, V Leventaki, ...
Oncogene 23 (32), 5426-5434, 2004
2362004
Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells
M Han, MR Vakili, H Soleymani Abyaneh, O Molavi, R Lai, A Lavasanifar
Molecular pharmaceutics 11 (8), 2640-2649, 2014
2352014
The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin
XB Xiong, Z Ma, R Lai, A Lavasanifar
Biomaterials 31 (4), 757-768, 2010
2272010
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
WH Wilson, SH Jung, P Porcu, D Hurd, J Johnson, SE Martin, ...
haematologica 97 (5), 758, 2012
2252012
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20